Fluorine in PDB 3ij9: Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Enzymatic activity of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
All present enzymatic activity of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase:
3.2.1.1;
Protein crystallography data
The structure of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase, PDB code: 3ij9
was solved by
C.Li,
R.Zhang,
S.G.Withers,
G.D.Brayer,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
33.38 /
1.85
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
52.380,
68.000,
129.950,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.4 /
20.7
|
Other elements in 3ij9:
The structure of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
(pdb code 3ij9). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 5 binding sites of Fluorine where determined in the
Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase, PDB code: 3ij9:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
Fluorine binding site 1 out
of 5 in 3ij9
Go back to
Fluorine Binding Sites List in 3ij9
Fluorine binding site 1 out
of 5 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:23.9
occ:1.00
|
F1
|
A:B9D501
|
0.0
|
23.9
|
1.0
|
C5
|
A:B9D501
|
1.4
|
25.5
|
1.0
|
O
|
A:B9D501
|
2.3
|
23.8
|
1.0
|
C6
|
A:B9D501
|
2.3
|
23.6
|
1.0
|
C4
|
A:B9D501
|
2.4
|
26.1
|
1.0
|
O4
|
A:B9D501
|
2.9
|
28.3
|
1.0
|
CB
|
A:TYR62
|
3.1
|
14.4
|
1.0
|
O5
|
A:BGC502
|
3.3
|
31.9
|
1.0
|
C5
|
A:BGC502
|
3.3
|
32.9
|
1.0
|
NE2
|
A:HIS101
|
3.6
|
12.9
|
1.0
|
C1
|
A:BGC502
|
3.6
|
30.9
|
1.0
|
O6
|
A:B9D501
|
3.6
|
26.0
|
1.0
|
O
|
A:TYR62
|
3.6
|
14.1
|
1.0
|
C1
|
A:B9D501
|
3.7
|
25.0
|
1.0
|
CE1
|
A:HIS101
|
3.7
|
13.6
|
1.0
|
C3
|
A:B9D501
|
3.7
|
25.2
|
1.0
|
C6
|
A:BGC502
|
3.8
|
31.8
|
1.0
|
CG
|
A:TYR62
|
3.9
|
15.2
|
1.0
|
CD2
|
A:LEU165
|
3.9
|
19.0
|
1.0
|
C2
|
A:B9D501
|
4.2
|
24.6
|
1.0
|
CA
|
A:TYR62
|
4.3
|
13.3
|
1.0
|
C
|
A:TYR62
|
4.3
|
14.2
|
1.0
|
CD1
|
A:TYR62
|
4.4
|
14.0
|
1.0
|
OD2
|
A:ASP197
|
4.5
|
14.6
|
1.0
|
O
|
A:HOH721
|
4.6
|
52.8
|
1.0
|
OD1
|
A:ASP197
|
4.7
|
15.1
|
1.0
|
C4
|
A:BGC502
|
4.7
|
33.0
|
1.0
|
CD2
|
A:HIS101
|
4.7
|
12.7
|
1.0
|
O3
|
A:B9D501
|
4.8
|
25.6
|
1.0
|
C3
|
A:BGC502
|
4.9
|
33.5
|
1.0
|
C2
|
A:BGC502
|
4.9
|
32.3
|
1.0
|
CD2
|
A:TYR62
|
4.9
|
14.2
|
1.0
|
CG
|
A:LEU165
|
4.9
|
21.3
|
1.0
|
O6
|
A:BGC502
|
4.9
|
30.6
|
1.0
|
ND1
|
A:HIS101
|
4.9
|
13.5
|
1.0
|
CG
|
A:ASP197
|
5.0
|
16.0
|
1.0
|
|
Fluorine binding site 2 out
of 5 in 3ij9
Go back to
Fluorine Binding Sites List in 3ij9
Fluorine binding site 2 out
of 5 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:44.7
occ:1.00
|
F1
|
A:B0D503
|
0.0
|
44.7
|
1.0
|
CX1
|
A:B0D503
|
1.4
|
45.3
|
1.0
|
OX5
|
A:B0D503
|
2.3
|
45.2
|
1.0
|
CX2
|
A:B0D503
|
2.4
|
45.2
|
1.0
|
OX2
|
A:B0D503
|
2.8
|
45.8
|
1.0
|
CX6
|
A:B0D503
|
2.9
|
45.8
|
1.0
|
CX5
|
A:B0D503
|
3.0
|
45.6
|
1.0
|
CX3
|
A:B0D503
|
3.0
|
45.2
|
1.0
|
OX6
|
A:B0D503
|
3.1
|
47.2
|
1.0
|
CX4
|
A:B0D503
|
3.6
|
44.9
|
1.0
|
F2
|
A:B0D503
|
4.2
|
45.3
|
1.0
|
OX3
|
A:B0D503
|
4.3
|
46.9
|
1.0
|
CE3
|
A:TRP203
|
4.7
|
17.6
|
1.0
|
OX4
|
A:B0D503
|
4.7
|
44.3
|
1.0
|
CD2
|
A:TRP203
|
4.8
|
16.8
|
1.0
|
CZ3
|
A:TRP203
|
4.8
|
18.8
|
1.0
|
O
|
A:HOH570
|
5.0
|
18.8
|
1.0
|
|
Fluorine binding site 3 out
of 5 in 3ij9
Go back to
Fluorine Binding Sites List in 3ij9
Fluorine binding site 3 out
of 5 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F503
b:45.3
occ:1.00
|
F2
|
A:B0D503
|
0.0
|
45.3
|
1.0
|
CX5
|
A:B0D503
|
1.4
|
45.6
|
1.0
|
CX6
|
A:B0D503
|
2.3
|
45.8
|
1.0
|
OX5
|
A:B0D503
|
2.3
|
45.2
|
1.0
|
CX4
|
A:B0D503
|
2.4
|
44.9
|
1.0
|
OX6
|
A:B0D503
|
2.8
|
47.2
|
1.0
|
OX4
|
A:B0D503
|
2.9
|
44.3
|
1.0
|
O
|
A:HOH570
|
3.3
|
18.8
|
1.0
|
N
|
A:ASP206
|
3.4
|
13.5
|
1.0
|
OD1
|
A:ASP206
|
3.4
|
17.3
|
1.0
|
CA
|
A:GLY205
|
3.4
|
14.6
|
1.0
|
CB
|
A:TRP203
|
3.5
|
15.1
|
1.0
|
C
|
A:GLY205
|
3.6
|
14.0
|
1.0
|
CX1
|
A:B0D503
|
3.7
|
45.3
|
1.0
|
CX3
|
A:B0D503
|
3.8
|
45.2
|
1.0
|
N
|
A:GLY205
|
3.8
|
15.1
|
1.0
|
CG
|
A:ASP206
|
3.8
|
16.7
|
1.0
|
CG
|
A:TRP203
|
4.2
|
15.4
|
1.0
|
CX2
|
A:B0D503
|
4.2
|
45.2
|
1.0
|
F1
|
A:B0D503
|
4.2
|
44.7
|
1.0
|
CA
|
A:ASP206
|
4.3
|
14.4
|
1.0
|
OD2
|
A:ASP206
|
4.3
|
16.2
|
1.0
|
CB
|
A:ASP206
|
4.4
|
14.6
|
1.0
|
O
|
A:GLY205
|
4.4
|
12.2
|
1.0
|
C
|
A:TRP203
|
4.7
|
14.1
|
1.0
|
CA
|
A:TRP203
|
4.8
|
14.0
|
1.0
|
CD2
|
A:TRP203
|
4.8
|
16.8
|
1.0
|
O
|
A:TRP203
|
4.8
|
14.2
|
1.0
|
OX3
|
A:B0D503
|
4.8
|
46.9
|
1.0
|
CD1
|
A:TRP203
|
4.9
|
16.3
|
1.0
|
|
Fluorine binding site 4 out
of 5 in 3ij9
Go back to
Fluorine Binding Sites List in 3ij9
Fluorine binding site 4 out
of 5 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F504
b:40.8
occ:1.00
|
F1
|
A:B0D504
|
0.0
|
40.8
|
1.0
|
CX1
|
A:B0D504
|
1.3
|
41.3
|
1.0
|
OX5
|
A:B0D504
|
2.3
|
39.1
|
1.0
|
CX2
|
A:B0D504
|
2.3
|
41.9
|
1.0
|
OX2
|
A:B0D504
|
2.8
|
44.0
|
1.0
|
CX6
|
A:B0D504
|
2.8
|
37.7
|
1.0
|
OX6
|
A:B0D504
|
2.9
|
32.6
|
1.0
|
CX5
|
A:B0D504
|
2.9
|
40.1
|
1.0
|
CX3
|
A:B0D504
|
2.9
|
41.6
|
1.0
|
CX4
|
A:B0D504
|
3.5
|
40.9
|
1.0
|
CD
|
A:LYS208
|
3.6
|
24.4
|
1.0
|
CA
|
A:GLY249
|
3.7
|
12.8
|
1.0
|
O
|
A:GLY249
|
3.7
|
15.1
|
1.0
|
C
|
A:GLY249
|
3.9
|
13.6
|
1.0
|
F2
|
A:B0D504
|
4.1
|
41.1
|
1.0
|
OX3
|
A:B0D504
|
4.2
|
44.1
|
1.0
|
CG
|
A:LYS208
|
4.3
|
20.2
|
1.0
|
O
|
A:HOH509
|
4.3
|
16.3
|
1.0
|
OD1
|
A:ASN250
|
4.3
|
14.7
|
1.0
|
OX4
|
A:B0D504
|
4.6
|
41.6
|
1.0
|
N
|
A:GLY249
|
4.8
|
11.4
|
1.0
|
CE
|
A:LYS208
|
4.8
|
26.4
|
1.0
|
NZ
|
A:LYS208
|
4.8
|
27.1
|
1.0
|
CB
|
A:LYS208
|
4.9
|
17.2
|
1.0
|
N
|
A:ASN250
|
4.9
|
14.0
|
1.0
|
|
Fluorine binding site 5 out
of 5 in 3ij9
Go back to
Fluorine Binding Sites List in 3ij9
Fluorine binding site 5 out
of 5 in the Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Directed 'in Situ' Elongation As A Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic A-Amylase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F504
b:41.1
occ:1.00
|
F2
|
A:B0D504
|
0.0
|
41.1
|
1.0
|
CX5
|
A:B0D504
|
1.4
|
40.1
|
1.0
|
OX5
|
A:B0D504
|
2.3
|
39.1
|
1.0
|
CX6
|
A:B0D504
|
2.4
|
37.7
|
1.0
|
CX4
|
A:B0D504
|
2.4
|
40.9
|
1.0
|
OX4
|
A:B0D504
|
2.9
|
41.6
|
1.0
|
OX6
|
A:B0D504
|
3.0
|
32.6
|
1.0
|
O
|
A:HOH509
|
3.5
|
16.3
|
1.0
|
CX1
|
A:B0D504
|
3.6
|
41.3
|
1.0
|
CB
|
A:PRO204
|
3.7
|
14.6
|
1.0
|
CX3
|
A:B0D504
|
3.8
|
41.6
|
1.0
|
F1
|
A:B0D504
|
4.1
|
40.8
|
1.0
|
O
|
A:ASP246
|
4.1
|
13.6
|
1.0
|
CX2
|
A:B0D504
|
4.2
|
41.9
|
1.0
|
C
|
A:PRO204
|
4.4
|
14.2
|
1.0
|
N
|
A:GLY205
|
4.5
|
15.1
|
1.0
|
CA
|
A:PRO204
|
4.7
|
14.2
|
1.0
|
O
|
A:PRO204
|
4.7
|
15.0
|
1.0
|
CG
|
A:PRO204
|
4.8
|
14.1
|
1.0
|
CA
|
A:GLY205
|
4.9
|
14.6
|
1.0
|
OX3
|
A:B0D504
|
4.9
|
44.1
|
1.0
|
O
|
A:HOH570
|
4.9
|
18.8
|
1.0
|
|
Reference:
R.Zhang,
C.Li,
L.K.Williams,
B.P.Rempel,
G.D.Brayer,
S.G.Withers.
Directed "in Situ" Inhibitor Elongation As A Strategy to Structurally Characterize the Covalent Glycosyl-Enzyme Intermediate of Human Pancreatic Alpha-Amylase Biochemistry V. 48 10752 2009.
ISSN: ISSN 0006-2960
PubMed: 19803533
DOI: 10.1021/BI901400P
Page generated: Wed Jul 31 19:31:53 2024
|